FindTrial
Sign In

Examining how continuous monitoring with early warnings benefit hospital patients

Evaluating the Impact of Continuous Remote Patient Monitoring and Early Warning System on Patient Outcomes in General Hospital Wards - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061082
Enrollment
3000
Registered
2024-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Control Intervention1: Nil: Nil

Sponsors

Turtle Shell Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult (18 years old and more) ward patient admitted in one of the identified study wards 2. Weight between 40kg-120kgs 3. They or legal representative are able and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Admitted for observation period of more than 4 hours 2. Weight below 40 kgs and above 120 kgs 3. Have any condition that could interfere with the subjects ability to lie flat or stable on the bed 4. Needs the use of equipments whose operation can interfere with Dozee signal 5. Patient not giving or unable to give consent 6. Pregnant 7. Patients with pacemakers

Design outcomes

Primary

MeasureTime frame
Enhanced Patient safety, Optimised health economicsTimepoint: At baseline—

Secondary

MeasureTime frame
Ease of usageTimepoint: At baseline—

Countries

India

Contacts

Public ContactDr Kumar Chokalingam

Turtle Shell Technologies Pvt Ltd

kumar.chokalingam@dozee.io9008349922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026